Tag: roche diagnostic

December 11, 2017 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

To deal with a shortage of surgical pathologists in the United Kingdom, the British National Health Service (NHS) is looking at solutions, such as deployment of digital pathology systems. According to a story in Pharma Times, the NHS is negotiating with Roche Diagnostics and partners to develop a program to implement digital pathology systems across the

View Article

New Lab Industry Trends Require Responses by Labs

CEO SUMMARY: One stark difference between the presentations delivered at last year’s Executive War College and this year’s presentations in New Orleans last week was near-unanimous recognition that the era of fee-for-service payment is soon to end! Speaker after speaker urged the audience to accept this marketplace reality. The common recommendation was for lab administrators and pathologists to take immediate steps to help their laboratories respond to this development in effective ways.

View Article

October 13, 2014 “Intelligence: Late-Breaking Lab News”

Quality management systems (QMS) have made inroads in some of the organizations that accredit clinical laboratories in the United States to the requirements of CLIA. Last month, COLA of Columbia, Maryland, acknowledged that it had recertified to the standards of ISO 9001: 2008. The recertification was obtained through the British Standards Institute. COLA earned its

View Article

February 24, 2014 “Intelligence: Late Breaking Lab News”

Maybe the tough financial environment here in the United States is causing Sonic Healthcare Ltd., one of this nation’s bigger lab players, to be more interested in overseas lab testing opportunities. On February 18, its CEO, Colin Goldschmidt, M.D., told investors that “We continue to seek out synergistic [laboratory] acquisitions and we believe that Germany

View Article

September 9, 2013 “Intelligence: Late Breaking Lab News”

bioMérieux is on the move. Last week it announced that it would pay $450 million to purchase privately-held BioFire Diagnostics of Salt Lake City, Utah. BioFire has a solid tech- nology base in molecular diagnostics. It developed and currently markets its FilmArray product, which it describes as a multiplex PCR system. BioFire also designed the LightCycler

View Article